ATRC news & sentiment — AtriCure, Inc.

MAY 23·Stock Traders DailyHigh

(ATRC) and the Role of Price-Sensitive Allocations

Atricure Inc. (NASDAQ: ATRC) shows strong near-term sentiment with neutral mid and long-term outlooks, featuring a mid-channel oscillation pattern. AI models suggest specific institutional trading strategies, including long, breakout, and short positions, with an exceptional 65.4:1 risk-reward setup targeting a 19.5% gain versus 0.3% risk. The analysis provides multi-timeframe signal insights, including support and resistance levels for various holding periods.

MAY 22·GuruFocus

Insider Sell Alert: Karen Prange Sells 3,000 Shares of AtriCure Inc (ATRC)

Karen Prange, a Director at AtriCure Inc (ATRC), sold 3,000 shares of the company on May 20, 2026, reducing her holdings to 26,373 shares. This transaction follows a pattern of 12 insider sells and no insider buys for AtriCure over the past year. The stock is currently priced at $28.65, giving it a GuruFocus Value of $39.37, indicating it is modestly undervalued with a price-to-GF-Value ratio of 0.73.

MAY 5·marketscreener.com

Earnings Flash (ATRC) AtriCure, Inc. Reports Q1 Revenue $141.2M, vs. FactSet Est of $139.7M

AtriCure, Inc. (ATRC) announced Q1 revenue of $141.2 million, surpassing the FactSet estimate of $139.7 million. Additionally, the company reported Q1 adjusted EPS of $0.00 per share, outperforming FactSet's estimate of $-0.06. This positive financial performance indicates stronger-than-anticipated results for the medical equipment company.

$ATRC

(ATRC) and the Role of Price-Sensitive Allocations

Insider Sell Alert: Karen Prange Sells 3,000 Shares of AtriCure Inc (ATRC)

Earnings Flash (ATRC) AtriCure, Inc. Reports Q1 Revenue $141.2M, vs. FactSet Est of $139.7M

News on $ATRC